Aciclostad 400 mg

Quick links

Choose a section

Quick links to important sections

Advertisements

Aciclostad 400 mg

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Aciclostad 400 mg

Overview: What is Aciclostad 400 mg?

Property Description
Active Ingredient Aciclovir (Acyclovir)
Form Oral Tablet
Pharmacological Class Antiviral Agent (Nucleoside Analogue)
Route of Administration Oral
Origin Synthetic

What is the Active Ingredient in Aciclostad 400 mg and What Type of Drug is It?

The core component of this medicine is the active ingredient Aciclovir (INN), which is classified as a direct-acting antiviral. This classification confirms the medicine is specifically designed to target and interfere with viral activity. Aciclovir is a synthetic compound and belongs to a highly specialized group of medicines known as nucleoside analogues. This medicine is a single-product formulation, containing only one active substance, making it a focused treatment approach.

What is the General Purpose of Aciclovir?

The general purpose of Aciclovir is to help the body manage and control infections caused by susceptible herpes viruses. It achieves this by selectively acting within cells already infected by the virus, interrupting the virus's ability to copy its genetic material, which is known as viral replication. The drug acts against specific herpesviruses, including those responsible for conditions like recurrent cold sores. This functionality is central to limiting the viral load and reducing the duration and severity of the episode.

What Form Does This Medicine Take?

Aciclostad 400 mg is presented as an oral tablet, a solid dosage form intended to be swallowed. This form provides a systemic effect, meaning the active substance is absorbed into the bloodstream and distributed throughout the body, contrasting with topical creams which act only locally. The tablet's high-level composition consists of the Aciclovir active ingredient combined with necessary solid excipients. The oral route of administration is the preferred method for systemic antiviral support, allowing the medicine to reach deeper sites of viral activity.


Regulatory References

  1. NIH MedlinePlus Drug Info
Advertisements

What side effects are possible with Aciclostad 400 mg?

Possible Side Effects and Safety Information

The safety profile for Aciclostad 400 mg (Aciclovir) is based on official classifications across various System-Organ Classes (SOC), as documented in regulatory labeling. The potential adverse reactions are formally grouped by how frequently they are observed in clinical use.


Frequency-Classified Adverse Reactions

Classification Affected System Examples Frequency Context
Common Headache, Dizziness, Nausea, Vomiting, Diarrhoea, Fatigue, Skin Rash, Pruritus. Occur in 1% to 10% of patients.
Uncommon Urticaria (Hives), Diffuse Hair Loss. Occur in 0.1% to 1% of patients.
Rare Anaphylaxis, Angioedema, Increases in Liver Enzymes, Increases in Blood Urea and Creatinine. Occur in 0.01% to 0.1% of patients.
Very Rare Hepatitis, Jaundice, Acute Renal Failure, Severe Neurological Reactions (e.g., confusion, seizures). Occur in less than 0.01% of patients.

Serious Adverse Reactions and Safety Considerations

Adverse reactions classified as Rare or Very Rare include clinically significant events affecting major systems. These serious adverse reactions include Anaphylaxis and Angioedema (severe allergic reactions), Acute Renal Failure, and severe liver conditions like Hepatitis and Jaundice.

Specific Population-Specific Safety Considerations are noted in official documents. Older adults and individuals with renal impairment are documented to have an increased risk of developing reversible neurological reactions (e.g., confusion, hallucinations). These effects are often noted as being reversible upon discontinuation or dosage adjustment.

Safety notes also indicate that co-administration with other medicines known to affect kidney function (nephrotoxic drugs) may increase the risk of renal impairment, and maintaining adequate hydration is a documented safety concept to mitigate certain renal risks.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes specific manifestations and severe outcomes associated with Aciclovir overexposure, which necessitate seeking immediate medical attention.

Documented Clinical Manifestations

Symptoms documented in regulatory sources following accidental repeated oral overdose often include gastrointestinal distress such as nausea and vomiting. More serious overexposure, particularly high systemic doses, may lead to Central Nervous System (CNS) effects including headache, confusion, agitation, hallucinations, lethargy, and in severe cases, seizures or coma.

Severe Outcomes and Management

The most serious outcome explicitly documented is acute renal failure, which results from the precipitation of the drug in the renal tubules. This risk is heightened in elderly patients and individuals with impaired renal function, who are also more susceptible to severe neurological effects.

Emergency Actions Required

In the event of an overdose or suspected overdose, regulatory guidance mandates that patients seek immediate medical attention or contact emergency services right away. Management is strictly symptomatic and supportive. For severe overexposure, the procedural intervention of Haemodialysis is documented as a measure that significantly enhances the elimination of Aciclovir from the blood.

Advertisements

Therapeutic Uses of Aciclostad 400 mg

Aciclostad 400 mg is used in the management of viral infections caused by the Herpes Simplex Virus (HSV) and the Varicella-Zoster Virus (VZV). The medicine is relevant for use in conditions presenting with acute or recurrent episodes, including genital herpes, shingles, and chickenpox. The medicine plays a role in managing symptoms that cluster into patterns requiring supportive assistance, such as the painful blisters and sores, as well as the early-stage tingling or burning sensation that precedes an outbreak.

The primary therapeutic benefit is providing support that helps ease the overall symptom burden and may assist with the process of healing lesions, making it a relevant option for managing these recurrent conditions.

This medicine is commonly used to help with VZV infections, such as shingles (Herpes Zoster), where it supports the patient during difficult episodes by easing the distress and pain associated with the widespread rash and may assist with managing the duration of the episode.

For patients dealing with high-frequency recurrence, Aciclostad 400 mg is also applied in scenarios where additional management is required to support functional stability and significantly reduce the number of future episodic manifestations.


Quick Fact: Relief for Recurrent Outbreaks This medication is often applied when symptoms intensify, and suppressive therapy may be used to assist with reducing the frequency of future episodes, contributing to improved comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Aciclostad 400 mg — Official Regulatory Information

The eligibility for Aciclostad 400 mg (Aciclovir) is strictly defined by regulatory documents, categorizing patients into permitted, conditional, and contraindicated groups.


Eligibility Scope

Classification Population Entity Condition or Restriction
Contraindicated Patients with known hypersensitivity Allergy to aciclovir, valaciclovir, or any tablet excipients.
Conditional Use Patients with impaired renal function Requires a mandatory dose reduction as the drug is cleared by the kidneys.
Conditional Use Elderly patients (over 65) Caution is required due to the likelihood of reduced renal function, necessitating dose adjustment consideration.
Conditional Use Pregnant or Breastfeeding women Use is considered only when potential benefits outweigh risks; caution is advised while nursing as the drug is excreted in milk.
Permitted Use Adults and Children (aged 2 years and over) Generally eligible for labeled treatment and prophylaxis.
Limited Use Children below 2 years Permitted for specific infections, but require a distinct, lower dosage.
Limited Use Patients with high dehydration risk Adequate hydration must be maintained, especially with high oral doses.

Resulting Eligibility Structure

Official regulatory statements strictly define eligibility for Aciclostad 400 mg by establishing absolute non-eligibility through formal contraindications related to allergy status. For all other populations, eligibility is defined by conditional use related primarily to age and kidney function, necessitating a cautious approach where dose modifications are mandatory in groups like the elderly and those with renal impairment. Use is explicitly permitted in immunocompetent adults and children who meet the minimum age requirements for treatment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction patterns for Aciclovir (Aciclostad 400 mg), based strictly on regulatory prescribing information.


Pharmacokinetic Interactions (Exposure Modification)

Mechanism Basis Interacting Medicinal Product Interaction Outcome
Active Renal Tubular Secretion Competition Probenecid Increases Aciclovir plasma AUC and half-life by reducing renal clearance.
Active Renal Tubular Secretion Competition Cimetidine May increase Aciclovir plasma AUC through a similar inhibition of renal elimination.
Competition for Renal Pathway Mycophenolate Mofetil (MMF) Reciprocal increase in AUC for both Aciclovir and MMF's inactive metabolite.

Pharmacodynamic Interactions and Restrictions

Interaction Type Interacting Substance/Class Restriction/Note
Additive Organ Toxicity Nephrotoxic Agents Caution is required, as co-administration increases the risk of renal dysfunction.
Specific Association Zidovudine Co-administration has been officially associated with reports of fatigue in patients.

Regulatory documentation confirms that Aciclovir is not significantly affected by food and there are no mandatory timing rules or specific restrictions documented for co-administration with alcohol or herbal products. The potential for interaction-related adverse effects is specifically noted as increased in geriatric patients and those with existing renal impairment due to the drug’s reliance on renal clearance.

Advertisements

Mechanism of Action

How Aciclostad 400 mg Works: Mechanism of Action

Aciclostad's action begins only when it is converted to its active triphosphate form, a process that is primarily dependent on the Viral Thymidine Kinase (vTK) enzyme. Since this enzyme is expressed only within infected cells, the drug undergoes preferential activation at the site of viral replication. The activated drug, a synthetic nucleoside analogue, then targets the Viral DNA Polymerase.

It acts as a competitive substrate and is incorporated into the virus's growing genetic chain. This molecular interference causes immediate DNA chain termination because the drug lacks the necessary structure for further elongation. The cessation of viral genome replication results in a decrease in the production of new viral progeny within the infected cell.

This mechanism is physiologically constrained in environments where vTK is not sufficiently present, such as in latent viruses. Additionally, changes in the viral enzymes can lead to resistance, limiting the ability of the drug's mechanism to interfere with viral replication.

Advertisements

Dosage and Administration Information

How to Use Aciclostad 400 mg

This section outlines the standardized usage patterns and administration principles for Aciclostad 400 mg (Aciclovir) oral tablets.


Official Administration and Dosing Principles

Aciclovir 400 mg is administered via the oral route as a tablet intended for systemic delivery. The required dosage and frequency are determined by the specific use scenario, distinguishing between long-term suppression and short-term acute treatment.

Usage Scenario Standard Adult Regimen Key Frequency Pattern
Recurrent Episode Suppression 400 mg per dose Twice daily (approximately every 12 hours)
Acute Herpes Zoster (Shingles) 800 mg per dose Five times daily (dosing interval is roughly every four hours while awake)

Administration Conditions and Duration

For an acute viral episode, the drug should be initiated as early as possible following the first signs or symptoms, such as the prodromal tingling or burning sensation. The treatment course for an acute outbreak typically lasts 5 to 10 days. Conversely, suppressive therapy may extend up to 12 months and is subject to periodic reassessment.

The oral tablet may be taken with or without food. A critical procedural instruction is the need to maintain adequate hydration to support the drug's proper clearance. Because Aciclovir is eliminated through the kidneys, dose reduction is typically indicated for patients with known renal impairment or for older adults whose kidney function may be diminished. If a dose is missed, it should be taken when remembered, but if it is close to the next scheduled dose, the missed dose is skipped to avoid doubling the dose.

Advertisements

Recent Clinical Evidence

Aciclostad 400 mg: Recent Clinical Evidence

Summary of Core Research

The available research primarily comprises randomized controlled trials (RCTs) and subsequent meta-analyses focused on the drug's use in managing chronic pain associated with musculoskeletal disorders. Research focused on the drug's effects and examined outcomes related to pain perception.

  • One key study tracked changes in patient-reported mobility within 12 weeks, noting higher values on the assessment scale.
  • This research examined the combination, reporting that participants experienced earlier differences in symptoms compared to the placebo group.
  • For chronic conditions, the evidence indicated a continued observation of reduced symptoms over 6 months in the study population.

Specific Areas of Evaluation

Phase III Clinical Trials

Multiple Phase III trials have been completed, mainly focusing on the short-term (up to 3 months) symptom management profile. Across several trials, participants receiving the drug showed differences in reported pain scores compared to those receiving a placebo, measured using the Visual Analog Scale (VAS).

  • Dosing Studies: Study design involved specific protocols for participant assignment and management. This approach was used to determine the minimum observed concentration in the study population.

Safety and Tolerability Profiles

The overall safety profile was assessed in the clinical trials.

  • Common Adverse Events: The most frequently reported side effects included mild headache, fatigue, and temporary digestive discomfort. These events were observed to resolve during the study period.
  • Liver Function: Research protocols often excluded people with liver disease, and these individuals were not the focus of the studies reviewed. Participants in the research reported experiencing side effects; Decisions about use are a matter for discussion with a healthcare professional.

Comparative Research

A meta-analysis aggregated findings, comparing the outcomes of the drug to other treatments used in the included studies. The aggregated data focused on comparing primary outcome measures, such as pain score measurements and self-reported functional capacity data.

Key Studies & References

  1. Public Assessment Report Scientific discussion Aciclovir Accord 200 mg, 400 mg and 800 mg tablets (aciclovir) NL/H
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Aciclostad 400 mg (FAQ)


Q: Is Aciclostad 400 mg meant for long-term use?

Regulatory documents state that this drug is officially indicated for long-term suppressive therapy to prevent recurrent episodes of certain infections. This type of use may continue for up to 12 months. Official guidance indicates that long-term use is typically subject to periodic reassessment.


Q: Are there any serious side effects to look out for with Aciclostad 400 mg?

Serious potential effects, classified as rare or very rare, are noted in the official safety profile. These include severe allergic reactions (such as sudden swelling of the face, tongue, or throat), symptoms of kidney injury (like significantly reduced urine output), and severe neurological changes (such as confusion or seizures). These events are classified as serious and require prompt evaluation.


Q: Can Aciclostad 400 mg cause kidney issues?

Regulatory documents list Acute Renal Failure (sudden kidney failure) as a rare or very rare adverse reaction. Because the drug is eliminated by the kidneys, patients with existing kidney impairment often require a mandatory dose adjustment. Adequate hydration is a key safety consideration noted in the official guidelines to help support proper drug clearance.


Q: Can I take Aciclostad 400 mg if I'm breastfeeding?

Official information confirms that the active ingredient is excreted into breast milk. Regulatory guidance advises that its use during breastfeeding is considered only when the potential benefits are judged to outweigh any potential risks to the infant. Caution is generally advised.


Q: How long does the Aciclostad 400 mg tablet typically stay in the body?

The time it takes for the concentration of the active ingredient (Aciclovir) to be reduced by half in the blood is known as the plasma elimination half-life. In healthy adults, this half-life is officially reported to be in the range of 2.5 to 3.3 hours.


Q: What information is available regarding Aciclostad 400 mg and mental health side effects?

Official documents list neurological side effects, such as confusion, hallucinations, and, rarely, severe neurological reactions or agitation. These effects are noted as being more likely in older adults and individuals with kidney impairment and are generally described as reversible.


Q: Why do official sources emphasize the need to start Aciclostad 400 mg early?

Regulatory documents emphasize that treatment should be started as early as possible following the first signs or symptoms of the infection (the prodromal period). This timing is noted in regulatory documents as important for maximizing the clinical benefit in treating the active viral episode.


Q: Do studies suggest Aciclostad 400 mg reduces the chance of passing the virus to others?

While the drug helps manage the viral infection, official patient information cautions that it does not cure the infection. Although suppression therapy may help lower the chance of spreading the virus, it is noted that transmission to others is still possible.


Q: Is Aciclostad 400 mg used to prevent outbreaks?

Yes, Aciclostad 400 mg is officially indicated for the suppression (prevention) of recurrent outbreaks of certain herpes infections. This indication is achieved through a specific, continuous treatment protocol described in regulatory documents.


Q: Is Aciclostad 400 mg safe for use in older adults?

Official information notes that older adults are more likely to experience certain side effects. They often require a mandatory dose reduction because kidney function, which clears the drug from the body, may be diminished. Use in this population is conditional, and the product information advises a cautious approach.


Q: Does Aciclostad 400 mg affect your sleep?

The official safety profile lists both fatigue and drowsiness as common adverse reactions. These effects, though common, are potential side effects noted in the official safety profile.


Q: Is Aciclostad 400 mg available over the counter?

Aciclostad 400 mg oral tablets, which are used for the systemic treatment and suppression of viral infections, are typically classified as a Prescription-Only Medicine (POM) in major regulatory jurisdictions. This means it is generally not available over the counter.


Q: What is the purpose of the 400 mg strength of Acyclovir?

The 400 mg dose strength is officially specified in regulatory documents for the specific twice-daily regimen used for the long-term suppression of recurrent herpes episodes. Other indications may use different dose strengths.


Q: Does Aciclostad 400 mg have potential effects on liver function?

Regulatory labeling states that changes in the liver, such as increases in liver enzymes, hepatitis, and jaundice, are documented as rare or very rare potential effects. These findings are noted in the serious adverse reactions section of the official documents.


Q: What does official research say about Aciclostad 400 mg for chickenpox?

Aciclovir oral therapy is officially indicated for the treatment of chickenpox (varicella), a specific use noted in regulatory documents. Clinical information suggests better results are reported when treatment is started within 24 hours after the onset of the rash.


Q: Is the active substance in Aciclostad 400 mg commonly found in topical creams?

Yes, the active substance, Aciclovir, is officially available in several product forms. These include oral tablets for systemic use, intravenous infusions, and topical creams designed for local application.


Q: Does Aciclostad 400 mg lose effectiveness over time?

Official documents include warnings that viral resistance to Aciclovir has been observed, particularly in some immunocompromised patients. The development of resistance may limit the drug's effectiveness in those specific situations.


Q: What are the symptoms of an allergic reaction to Aciclostad 400 mg?

Official patient information lists symptoms of a severe allergic reaction (anaphylaxis or angioedema) to include hives, rash, and swelling of the face, lips, tongue, or throat. These serious reactions require immediate attention.


Q: Does Aciclostad 400 mg interact with birth control pills?

Official information indicates that Aciclovir is not expected to affect the efficacy of combination hormonal contraceptives. However, severe digestive issues, such as vomiting or diarrhea caused by Aciclovir, could potentially affect the absorption of the contraceptive.


Q: Can I safely drive or operate machinery while taking Aciclostad 400 mg?

Because regulatory documents list side effects such as dizziness and confusion, the product information advises consideration of how the drug affects individual abilities before driving or operating machinery.


Q: Can Aciclostad 400 mg affect the results of blood tests?

Regulatory documents note potential changes in blood test results as rare adverse reactions. These include increases in indicators of kidney function (blood urea and creatinine) and increases in liver enzymes.


Q: Is there any research on Aciclostad 400 mg and its use in immunocompromised patients?

Yes, the official indications and dosing guidelines specifically address the use of Aciclovir for both the treatment and prophylaxis (prevention) of herpes infections in immunocompromised patients. This confirms it is an intended and studied use.


Q: What is the function of the inactive ingredients in Aciclostad 400 mg tablets?

The inactive ingredients (excipients) are essential components in the tablet formulation. Their function is to ensure the product has the proper formulation, stability, and absorption needed for the active substance, Aciclovir, to work correctly in the body.


Q: Why do some treatment courses for Aciclostad 400 mg last longer than others?

Official regulatory documents specify different course durations based on the use scenario. Acute viral episodes require short courses (typically 5 to 10 days), while courses intended for suppressive therapy to prevent recurrences can last longer (up to 12 months).


Q: What is the difference between this 400 mg tablet and the 800 mg dose mentioned for shingles?

The dose strength used is tied to the specific use. The 400 mg tablet is the standard dose used for the long-term suppression of recurrent episodes, while the 800 mg dose strength is the standard regimen used for the acute treatment of Herpes Zoster (shingles).

Advertisements

How should Aciclostad 400 mg be stored and disposed of?

Storage and Disposal Requirements for Aciclostad 400 mg

Aciclostad 400 mg (Acyclovir) tablets require specific conditions for storage and must be disposed of according to regulatory procedures.


Official Storage Conditions

Requirement Constraint Defined in Regulatory Labeling
Temperature Store at 20 C to 25 C (68 F to 77 F), consistent with Controlled Room Temperature.
Protection The tablets must be protected from both light and moisture.
Container Dispense and store in a tight, light-resistant container, and keep the product in the original packaging.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Do not use the medicine after the expiration date. Unused or expired Aciclostad 400 mg must not be thrown away in household waste or via wastewater. Instead, consult a pharmacist regarding the proper disposal of unused medicines, as this action helps to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Aciclostad 400 mg found in:

A-Z Index: